Grifols (GIKLY) Change in Receivables (2010 - 2020)

Grifols (GIKLY) posted Change in Receivables of $1.5 million for Q1 2020, up 109.81% quarter-over-quarter from -$15.1 million in Q4 2019, and up 100.9% year-on-year from $738505.3 in Q2 2019.

Grifols (GIKLY) Change in Receivables (2010 - 2020) Analysis & Trends

Grifols (GIKLY) has reported Change in Receivables for 10 consecutive years, with $1.5 million the latest figure, recorded in Q1 2020.

  • Change in Receivables for Q1 2020 came in at $1.5 million, up 100.9% year-over-year; the trailing twelve-month figure through Mar 2020 was -$160.7 million (up 27.66% YoY), and the FY2025 annual result was -$37.2 million, up 17.0% from the prior year.
  • Change in Receivables was $1.5 million for Q1 2020 at Grifols, up from -$15.1 million in the prior quarter.
  • Over five years, Change in Receivables peaked at $81.5 million in Q4 2017 and troughed at -$163.9 million in Q1 2019.
  • Average Change in Receivables over 5 years is -$4.0 million, with a median of $3.5 million recorded in 2016.
  • Year-over-year, Change in Receivables surged 2206.94% in 2017 and slumped 1195.73% in 2019.
  • Over 5 years, Change in Receivables stood at $3.5 million in 2016, then soared by 2206.94% to $81.5 million in 2017, then tumbled by 79.25% to $16.9 million in 2018, then plunged by 189.44% to -$15.1 million in 2019, then surged by 109.81% to $1.5 million in 2020.
  • Per Business Quant data, the three most recent Change in Receivables figures were $1.5 million in Q1 2020, -$15.1 million in Q4 2019, and -$163.9 million in Q1 2019.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Receivables (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn -
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn 595.00 Mn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn -87.00 Mn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn -
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn -
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn -413.00 Mn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn -134.00 Mn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn -
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Grifols - - - -

Historic Data

Download Data
DateValue
Mar 31, 2020 1.48 Mn
Mar 31, 2020 1.48 Mn
Dec 31, 2019 -15.12 Mn
Dec 31, 2019 -15.12 Mn
Mar 31, 2019 -163.95 Mn
Mar 31, 2019 -163.95 Mn
Dec 31, 2018 16.91 Mn
Dec 31, 2018 16.91 Mn
Jun 30, 2018 -90.04 Mn
Jun 30, 2018 -90.04 Mn
Mar 31, 2018 14.96 Mn
Mar 31, 2018 14.96 Mn
Dec 31, 2017 81.48 Mn
Dec 31, 2017 81.48 Mn
Jun 30, 2017 -19.98 Mn
Jun 30, 2017 -19.98 Mn
Mar 31, 2017 61.00 Mn
Mar 31, 2017 61.00 Mn
Dec 31, 2016 3.53 Mn
Dec 31, 2016 3.53 Mn